<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0028-3746</journal-id>
<journal-title><![CDATA[Neumología y cirugía de tórax]]></journal-title>
<abbrev-journal-title><![CDATA[Neumol. cir. torax]]></abbrev-journal-title>
<issn>0028-3746</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Neumología y Cirugía de Tórax; Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas; Sociedad Cubana de Neumología; Sociedad Paraguaya de Neumología; Sociedad Boliviana de Neumología.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0028-37462016000400263</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[La codificación CIE-10 en la enfermedad pulmonar intersticial en el Instituto Nacional de Enfermedades Respiratorias (INER) ¿sigue siendo aplicable?]]></article-title>
<article-title xml:lang="en"><![CDATA[ICD-10 coding regarding Interstitial Lung Diseases at the National Institute of Respiratory Diseases (INER), is it still applicable?]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Betanzos-Paz]]></surname>
<given-names><![CDATA[José Iván]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mejía-Ávila]]></surname>
<given-names><![CDATA[Mayra Edith]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Buendía-Roldán]]></surname>
<given-names><![CDATA[Ivette]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2016</year>
</pub-date>
<volume>75</volume>
<numero>4</numero>
<fpage>263</fpage>
<lpage>267</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0028-37462016000400263&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0028-37462016000400263&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0028-37462016000400263&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Antecedentes:  Las enfermedades pulmonares intersticiales (EPI) son un grupo heterogéneo de enfermedades que afectan al intersticio pulmonar.  Material y métodos:  Se realizó un estudio observacional, retrospectivo y descriptivo de los pacientes egresados de enero de 2010 a junio de 2015, con los códigos CIE-10: (J67) neumonitis hipersensitiva debida a polvo orgánico, (J82) eosinofilia pulmonar no clasificada en otra parte, (J84) otras enfermedades pulmonares intersticiales; y los diferentes numerales disponibles en la clasificación para cada uno de ellos para corroborar si la codificación comprendía al total de diagnósticos emitidos en el Servicio de Enfermedades Intersticiales del Instituto.  Resultados:  Se evaluaron 1,279 pacientes egresados, clasificándolos de acuerdo al diagnóstico del médico tratante, resultando los más frecuentes: EPI, 538 (42%); NH, 223 (17.4%); FPI, 185 (14.4%); fibrosis pulmonar no clasificable (FPNC), 155 (12.1%) y NINE, 95 (7.4%); mientras que el CIE-10 los agrupó en forma indistinta.  Conclusiones:  Con los resultados obtenidos en este trabajo corroboramos que la codificación CIE-10 para enfermedades intersticiales es insuficiente para la heterogeneidad de diagnósticos y se debe unificar para poder realizar estudios epidemiológicos en un futuro.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Background:  Interstitial lung disease (ILD) is a heterogeneous group of diseases that affects pulmonary interstitium.  Material and methods:  An observational, retrospective and descriptive study was conducted in patients discharged from January 2010 to June 2015, with the codes ICD-10: (J67) hypersensitivity pneumonitis, (J82) eosinophilia unclassified, (J84) other interstitial lung diseases, and the different numerals available for each of them. To evaluate if clinical diagnosis reported in the interstitial lung diseases service were similar to ICD coding used.  Results:  We included 1,279 patients, classifying them according to the physician's diagnosis, the most common diseases reported was: ILD 538 (42%), HP 223 (17.4%), IPF 185 (14.4%), unclassifiable pulmonary fibrosis (UPF) 155 (12.1%) and NSIP 95 (7.4%), while the ICD-10 grouped them indistinctly.  Conclusion:  The results obtained in this study corroborated that ICD-10 code using in ILD is insufficient for all the diagnoses included in this group so it is necessary unify the codes to perform epidemiological studies in the future.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[CIE-10]]></kwd>
<kwd lng="es"><![CDATA[enfermedad pulmonar intersticial]]></kwd>
<kwd lng="es"><![CDATA[codificación]]></kwd>
<kwd lng="en"><![CDATA[ICD-10]]></kwd>
<kwd lng="en"><![CDATA[interstitial lung disease]]></kwd>
<kwd lng="en"><![CDATA[coding]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Una mirada general a las enfermedades pulmonares intersticiales y una específica a la fibrosis pulmonar idiopática]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marcos]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Montero]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Otéro]]></surname>
<given-names><![CDATA[GI]]></given-names>
</name>
</person-group>
<source><![CDATA[Galicia Clin]]></source>
<year>2013</year>
<volume>74</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>13-22</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epidemiology of idiopathic pulmonary fibrosis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ley]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Collard]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Epidemiol]]></source>
<year>2013</year>
<volume>5</volume>
<page-range>483-92</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hypersensitivity pneumonitis insights in diagnosis and pathobiology]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Selman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pardo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[King]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2012</year>
<volume>186</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>314-24</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tendencia de la mortalidad por enfermedades intersticiales en México, período 2000-2010]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez-Briseño]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[García-Sancho]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Plata]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Franco-Marina]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Torre-Bouscoulet]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Padilla]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Neumol Cir Torax]]></source>
<year>2014</year>
<volume>73</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>179-84</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Rheumatoid arthritis-associated interstitial lung disease lung inflammation evaluated with high resolution computed tomography scan is correlated to rheumatoid arthritis disease activity]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez-Dórame]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mejía]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mateos-Toledo]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas-Serrano]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Reumatol Clin]]></source>
<year>2015</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>12-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Interstitial lung disease related to rheumatoid arthritis evolution after treatment]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rojas-Serrano]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[González-Velásquez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Mejía]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Rodríguez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Carrillo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Reumatol Clin]]></source>
<year>2012</year>
<volume>8</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>68-71</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="">
<collab>WHO</collab>
<source><![CDATA[Classifications. International classification of diseases (ICD). Anexo: CIE-10. Enfermedades del sistema respiratorio]]></source>
<year>29-0</year>
<month>6-</month>
<day>20</day>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="">
<source><![CDATA[International Statistical Classification of Diseases and Related Health Problems]]></source>
<year></year>
<edition>10</edition>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Travis]]></surname>
<given-names><![CDATA[WD]]></given-names>
</name>
<name>
<surname><![CDATA[Costabel]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Hansell]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An official American Thoracic Society/European Respiratory Society statement update of the international multidisciplinary classification of the idiopathic interstitial pneumonias]]></article-title>
<collab>ATS/ERS Committee on Idiopathic Interstitial Pneumonias</collab>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2013</year>
<volume>188</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>733-48</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Idiopathic pulmonary fibrosis diagnosis, epidemiology and natural history]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sgalla]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Biffi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Richeldi]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Respirology]]></source>
<year>2016</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>427-37</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Characterisation of patients with interstitial pneumonia with autoimmune features]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oldham]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Adegunsoye]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Valenzi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur Respir J]]></source>
<year>2016</year>
<volume>47</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1767-75</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fischer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Antoniou]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[KK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An official European Respiratory Society/American Thoracic Society research statement interstitial pneumonia with autoimmune features]]></article-title>
<collab>ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD</collab>
<source><![CDATA[Eur Respir J]]></source>
<year>2015</year>
<volume>46</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>976-87</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
